SPH Biochemical & Pharmaceutical

SPH Biochemical & Pharmaceutical is a prominent subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., focused on the development and production of biochemical medicines. The company maintains a robust portfolio of products including hormones, enzymes, and cardiovascular treatments, with a history dating back to the 1940s. It operates advanced manufacturing facilities that comply with international GMP standards, producing key products such as Urokinase and Heparin. As a vital component of the SPH group, the company integrates research, production, and sales to serve both domestic and international healthcare markets. Their expertise extends to the production of active pharmaceutical ingredients (APIs) and finished dosage forms across multiple therapeutic areas.